Ali M. Atoom

7 ta ish

Amman Private University

1. Targeting the proliferation of glioblastoma cells and enhancement of doxorubicin and temozolomide cytotoxicity through inhibition of PFKFB4 and HMOX1 genes with siRNAs

   Hamzeh J. Al‐Ameer, Malek Zihlif, Ahmed O. Maslat +13

   Maqola202512 iqtibos

   ABIABI:AkademIndex/2026.other.342311

2. Aptasensors in colorectal Cancer: Emerging tools for precision diagnostics

   Qamar Abuhassan, Ali M. Atoom, R. Roopashree +5

   MaqolaAdvanced biosensing and bioanalysis techniquesClinica Chimica Acta20251 iqtibos

   ABIABI:AkademIndex/2025.article.002589

3. β-Glucan in antiviral defense: mechanisms, immune modulation, and therapeutic prospects

   Ali M. Atoom, Waleed K. Abdulsahib, S. Renuka Jyothi +6

   Sharh maqolaPolysaccharides and Plant Cell WallsFolia Microbiologica20250 iqtibos

   ABIABI:AkademIndex/2025.review-article.000153

4. Acute respiratory viral inflammation and metastatic dormancy: direct evidence, mechanistic convergence, and research priorities

   Ali M. Atoom, Jasur Rizaev, D. Polatova +5

   MaqolaOAOchiq kirish20260 iqtibos

   ABIABI:AkademIndex/2026.article.051092

5. Oncolytic virotherapy at the tumor microenvironment–CAR Therapy interface: Mechanisms, clinical translation, and future directions

   Ali M. Atoom, Jasur Rizaev, D. Polatova +5

   MaqolaOAOchiq kirish20260 iqtibos

   ABIABI:AkademIndex/2026.article.057512

6. Viral exploitation of p300/CBP at the virus-cancer interface: Chromatin regulation, oncogenesis, immune evasion, and therapeutic targeting

   Ali M. Atoom, Jasur Rizaev, D. Polatova +5

   MaqolaOAOchiq kirish20260 iqtibos

   ABIABI:AkademIndex/2026.article.057531

7. Interferon Regulation in Cancer: Tumor Vulnerabilities, Oncolytic Virus Exploitation, and Emerging Immunotherapeutic Strategies

   Ali M. Atoom, Jasur Rizaev, Djamila Sh. Polatova +5

   MaqolaOAOchiq kirish20260 iqtibos

   ABIABI:AkademIndex/2026.article.117697